+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search for: Strategic Perspectives : Ovarian Cancer - Overview of Current and New Developments

Bulk Paclitaxel - Global Strategic Business Report - Product Thumbnail Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • June 2026
  • 184 Pages
  • Global
From
Alpha Emitters - Global Strategic Business Report - Product Thumbnail Image

Alpha Emitters - Global Strategic Business Report

  • Report
  • June 2026
  • 179 Pages
  • Global
From
Doxorubicin - Global Strategic Business Report - Product Thumbnail Image

Doxorubicin - Global Strategic Business Report

  • Report
  • June 2026
  • 215 Pages
  • Global
From
Ovarian Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Ovarian Cancer Drugs - Global Strategic Business Report

  • Report
  • June 2026
  • 326 Pages
  • Global
From
From
From
PARP Inhibitor Biomarkers - Global Strategic Business Report - Product Thumbnail Image

PARP Inhibitor Biomarkers - Global Strategic Business Report

  • Report
  • June 2026
  • 278 Pages
  • Global
From
From
From
From
Gemcitabine Hydrochloride - Global Strategic Business Report - Product Thumbnail Image

Gemcitabine Hydrochloride - Global Strategic Business Report

  • Report
  • June 2026
  • 380 Pages
  • Global
From
From
From
Carcinoembryonic Antigen - Global Strategic Business Report - Product Thumbnail Image

Carcinoembryonic Antigen - Global Strategic Business Report

  • Report
  • June 2026
  • 485 Pages
  • Global
From
Genitourinary Drugs - Global Strategic Business Report - Product Thumbnail Image

Genitourinary Drugs - Global Strategic Business Report

  • Report
  • June 2026
  • 194 Pages
  • Global
From
From
From
DNA Repair Drugs - Global Strategic Business Report - Product Thumbnail Image

DNA Repair Drugs - Global Strategic Business Report

  • Report
  • June 2026
  • 217 Pages
  • Global
From
Tumor / Cancer Markers - Global Strategic Business Report - Product Thumbnail Image

Tumor / Cancer Markers - Global Strategic Business Report

  • Report
  • June 2026
  • 180 Pages
  • Global
From
Gene Panel - Global Strategic Business Report - Product Thumbnail Image

Gene Panel - Global Strategic Business Report

  • Report
  • June 2026
  • 239 Pages
  • Global
From
Loading Indicator